Pylori Duo for new H. pylori infection treatment
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial tests a treatment called Pylori Duo for people newly diagnosed with H. pylori infection. It aims to both treat the infection and prevent it from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have an active H. pylori infection confirmed by a breath test or stomach biopsy.
- You have never been treated for H. pylori before.
- You do not have any serious health conditions (like severe liver, kidney, heart, or immune problems).
- If you can become pregnant, you agree to use birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of a probiotic (Saccharomyces boulardii) plus a standard bismuth-based four-drug treatment for people whose H. pylori infection has not been cured by previous treatments. It aims to see if adding the probiotic helps the treatment work better and cause fewer side effects.
This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.
This trial tests whether a combination of two natural plant compounds, diosmin and hesperidin, can safely and effectively treat Helicobacter pylori (H. pylori) infection in people who have not been treated for it before. The goal is to see if this therapy offers a new option for clearing the bacteria.
This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.
This trial studies how to eradicate Helicobacter pylori (a germ in the stomach) and monitor follow-up results after treatment. You may be a candidate if you have confirmed infection and have not taken certain stomach medicines or antibiotics recently.
This study compares two different antibiotic treatment plans for H. pylori, a common stomach bacteria that causes ulcers and digestive problems. The trial tests whether a higher dose of one medication (vonoprazan) works better than a different antibiotic combination.
Hear when a new Helicobacter Pylori Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.